GSTP1 contributes to chemoresistance by metabolizing and inactivating chemotherapy drugs, reducing their efficacy. For example, GSTP1 can conjugate GSH to platinum-based drugs like cisplatin, facilitating their removal from cells. This detoxification process limits the drug's ability to induce cell death in cancer cells, leading to treatment failure.
